Not all clients with CLL involve therapy. In spite of all new advancements, the iwCLL however recommends watchful observation for patients with asymptomatic condition.86 This recommendation is predicated on not less than two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (